pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-302b |
Genomic Coordinates | chr4: 112648485 - 112648557 |
Description | Homo sapiens miR-302b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-302b-5p | ||||||||||||||||||||||||||||||
Sequence | 11| ACUUUAACAUGGAAGUGCUUUC |32 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BTBD7 | ||||||||||||||||||||
Synonyms | FUP1 | ||||||||||||||||||||
Description | BTB domain containing 7 | ||||||||||||||||||||
Transcript | NM_001002860 | ||||||||||||||||||||
Other Transcripts | NM_018167 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BTBD7 | |||||||||||||||||||||
3'UTR of BTBD7 (miRNA target sites are highlighted) |
>BTBD7|NM_001002860|3'UTR 1 GAGCAACCTCCAAGTCGTCTGTGCCTGAGATGTGAAACATCCCATTTTATGATGTAACCCAACAACTTACAGACCAGTTC 81 ATCAATGCCAGCTGATAACTCGGTTTCACATGATTTTGTTCTAGTTTTTGTGTATATATGTGTTTATTAGACATGGCATG 161 CTAAGAAGGTTTTGTTTTTTTTTTTTAATGTTGCATCTGTCTAATTTGTCTTTGAACAATTATGTCGGGAGGCATTTTTA 241 AGAACAAGCAGGCTGGCACTTTTTATTTCTCTTTACAAATGATGGAATTTTTTTGCACTTGTACATTTATTTTCTCTGTA 321 TTGATTTTATATCAGTATGTTAAACTTTATTGCCACATTTAAAGGACTGTATTTTCATACTTTTTTGCATTTTACCTTTC 401 ATCTACCAATCCATGTGCATTGGATTGCACACTAAGATGTATTTTCTTACGAAATAGTTCTGTGTTTATTTTTTAATTAT 481 AGAAATTCCAAAGAACAGCACATCAGAATGCTCCTCTCTTTTCAGTAATTGTTTTAGTTCAGAGATCTTCCCGCTCAGCC 561 TCCATAAATCTAATGTCATTTTTTTTTTAATAAGTCCTAGGAGCTGGGCTTCATTCCTCCAGCGGGAGTCCAGTCAGGGT 641 CCTGAAGTTTGCTGGTTCAGGAAAGAACAGGAAAGAGAAAAGCCTTCTGTGCCCAGGCTAAAGCTGTTACATTTCCACAG 721 TGTGGATGCAGTCAGAATCCCTGCACATTCTGGTCATAAGGATTAGAGTCACCAGATGAGGCTCTAAACAGATCGCATCC 801 CTTGGAATTAGAAAGCAGTGGAGACCGGGCGCAGTGACTCACACCTGTGATCGGCACTTCGGAAGGCCGAGGCGGGCAGA 881 TCACTGAAGCTCAGGAGTTCAAGACCAGCCTGGGCAACATGGCGAAACTCCATTTCTATAAAAAATACAAAAAAAAAAAA 961 ATCTAGCCAGGCGTGGTGGTGCGTGCCTGTAGTCCCAGCTACTTGGGGGGCTGAGGTGGCAGGATCGCTTGAGCCTGGGA 1041 GGTTGAGACTGCAGTGAGCCAAGATTGCACCACTGTGCTCCCACCTGGGCAACAGTGAGACCCTGTCTCAAAAAAAAAAA 1121 AAAAGGCAGTGGAAATAGAGAAGTAACTTAAAGGTCACACTGACAGAATTTCTGGTTCTGAGCGTCAACTCTCCAGCTGT 1201 GATGGCGGAACTGACTGCTTGCTGCCTTTAATTGTCTTGCTCTCTATGGGAAAAAAACAAAAGGGCTTCAGTCTCATGGA 1281 TGTTATTTGGTGTTTGTAAAGATACGTTTTCTTTTAAACGATTTTCAAAATATGTCTAAATTTTGGTGTTGTGTAATGCA 1361 TAATGCTTTCTCACCAACAGAAAAAAGGAAAAAAATTGTTTTCAGTTAAACACTACATGTCCTACTTGAACTCCACTGGG 1441 ACGCTGGTTTGGCATTTACTAAACCACTGAGCACATGGGGTCTTTCAGGATCCTCTCCCTTGGAAGGGCAATGTGTGAGC 1521 TAAGGACTGTTTTTTTTCTTACTCTCCAATGTAAATATATGAGTATTTGAGTTTTTAAATCACTTCAACATTATTTGAGC 1601 ATTTACTTTGTATTTTTACAAACACATAAACACACAGCCGTAGCACTTAGAAGAAAAGAGGCTTTCTAAGCATTCCTTCC 1681 TCTGCAGGATATTTGGGATCCTCTTTTCTATGTATGTATATATATAAAAAACTATGAATCACTCACACTCACTCGAAAAC 1761 TATGCAGGGCTAGGGAGCGTTTATGAGCTACCGGGTAAATGAATTACATGCACTTTGAAGTAAATAGGTTTTCTATTGGG 1841 TGTCAACAACGCTGATTTCTCCCAAAACTATAGTTTCTCTTACGGTCTTTTCCTCCTTTACCCTGTGGATATACACTCAG 1921 GAATAATCTGACATTTTAGAAAAGCCGAACAGTAGATAGTCTCCAAGATGGGAAACATGTCGTGTGTCTGCACGCCCCGG 2001 CAAACTGCCGCCACTCGTTCTGCTGCCTGACTGGTTAGCTGCTGTGCGGGTGCGCTCGGTGACACTGGTGGTGGTGCACG 2081 CTCCCGAGCTCCCAGAGTTAACACTAATCTGCAGGTCGGCTGTGCATCGCATTCGAGGCTCCTTTTTTAAAGAGAAAAGC 2161 ATAGGCCTCTGTTCTCATTTGTAAGAAGTTTGACTCATAATAGAAGACGGTGTCTTTTGAAGCCCAGTCTCTGTCTGTCT 2241 TCAGAAACAAAAGTGAATGCCGTCATGTTCCTTGATGTGTGTTTCTGCCACATATGTATGTTGACATGTTCATGTACTGC 2321 GCCGGTACTGCAAGTAAGACTCAACAGACCTAATTTGGATGGGGAGAAAAACTCTCATCCCTGACCCTTCCCCCCCCGCA 2401 AATGTTAGACCAGAGCTGTTGATCCCACACATTCATTTTTCTGAAAATTCATGAACTATTCTCTCATATCCCTGAAATAT 2481 AAAAGTAAGTGGCCACTATTCCTAAGATTATTTAGTTTATAAAGTTTGCTTTTAATCATACAATAGCTTACCTGGCTAAA 2561 ACTTTGCGTATAAAGGGAAAACTTGCTTTAATCTGTGGGATTGCGGACCGATGCGACTTGCAGAAGGTAAACAGGCGTGG 2641 GTTTTGTGTGCGTTAGGTTAGGTGTTAGTGGACTTTTAATGTATCTTGTGAAGTATGGTTACTAGGGTAGGTTCAAGAGC 2721 TACATGCCTCTGGCTTTTGAACCCATCTATTAAATCTTTTTTAATGCTGTACTAAGATAAATGTGAAGTCTGAGTAAGGT 2801 TGCTCTCAGAAAAAAAAAAAAAGCATATATATATATAAAATAAAATTTAGGCCATGGGAACTGGCATTTTACTTGGTATA 2881 GGAATTTAATGAGAACCAAATCACAAAAATACCAGATCTCCTTTTGAGATCGTGGACAATCAGGCCTTTGGACAATCACC 2961 GCTTCCAGTGCCCGCTGTGCGTTGAGGTTAGAGACCTACCGTTTACACGCTAGAGCCGAGAGGACGTTCAAGTTTCTTAA 3041 AGATGCTGTTGGTCTTTTTTCTTATGTTATTGTTTTAGTTTTGTGATTTTGATGAATAATTGAAGTTCAGAGTCACCCGT 3121 GGCTCCTAAGGAAAAAACAGCATCATGAAAGGCAAAAAGTATTTGAAACGTAATTGTTTCAATTTTCCACGCCCGTTCTC 3201 ACATGCCCCCTTTAGCTTTATTTCTGGGAACATGTCACTAGACCTCAGCTAGCCTGACACCGCAATAACCCGTTAGGCTT 3281 TGAGGCTTTTCAGTGAATTCTTGACATTTAAATCTTCTTATAGAATTCTTTATGAAGCCTTAACTAATTCTTGTTTTTGC 3361 TTCCTCAGAAACTTTTTATTGCATCTGCCATCCTTCATTGGATTTTTGTTTTGGTTTGTTGTTGCCATTCTAGCAATGAG 3441 CTTAGTCCTTGTACATCTGCATTAAGGTGCCGATGCAGAAGGCAAATTGGAAACACGCGCCAGCGGCAGTGGGGCTCAAA 3521 GCCGACCTCCATGCATCATTCTCTAGAGTTGAAAGGATTGACATTTCTCAGTAACTACCCGGCAAAATATATATTTTCAT 3601 AATGTTGAATTTGCCTTTTAGGAAAACAATGTTTCATGAAACACTTGTAAGATACTTATTTTGAAATTAATTATAAGGCA 3681 TTCATATTTTTAGGACTGAATTCAAAGGGAAATGCTTCTTTGACTTTTTTTCATTGTTCGGTTGACTTTCAGCTTTCTGG 3761 AGTGACAAAGCAGCAGTGATGGGTGCTATTCCTGGTTCTGTGGTGGTTTACTTTGTCTACTAAGTGATTTACTTTCAAAC 3841 CTCATTACAGATAATCTTACTAAAAGACTTAACATGCACACTGCTAAAAGGTGTTTTACTGTTTTCCATTAACGCTGTTG 3921 TATGAACAATATTTGGTGACATGTTGTCTTTTTGTCCTGTAGATTGTCATATCTGTTATGTAGTTATCCTTTTGGCAAGT 4001 CCTTTGATTTTTTTTTCCTCTAGAAAATCCTCAGACTGTCAATCTTCCATATTTTGAATATTATAATGCTGTGGCCATTT 4081 CTATAGAAAGATTACTTGCAAGTGTGTGTCTTGAAAATAACCTCTTGTATTTGTGTGTTTATGTGAGTTCTGTCTAAGAG 4161 ATCAGATAAGCTCTGGAAGCTTCATCATCTGTACCTACATGTAACTGTATCTGGGTTACATGGGCAGGCGGTACCAAGTC 4241 CTGCTCTTCGATGGGGTGGCTGAGAGATAAAGGTTCCTGAACTCTCCTTGCTGTGTATGCACCACATCTGTACTTCAGAG 4321 AGGTGGAAAATCATCTACAACACTGCGTTTCTTGTGGTTGTGCTGTTACTGGTATAAAGTCAAGTGCCTTCAATGCTAAA 4401 GGCTCAGAAATTTTTCTTAAACTGATTTCATGTCCTATGCAAGTGTTTTCTACAACCTGCATAACCAGTACTTTGTAAAA 4481 CTTGTTTACGCTTCAATTGTACATAGTGATTTTTAAAGAAATATATAGTATTTTTATTTAGGTACCTCCAAACTTGAATT 4561 CGTCTGTGTGAAGCATTGTAAAACGATACATTTCTCTTTTGAGTACCATTACAGTTGTACAGAGGTTTTCACTGCTTCTA 4641 TTTTTCTACTGTTACTGATAAGCATGTAACACTGACTTTATCCTACATATAGTTGGCATTTCAAATAAATGGCTTGTATA 4721 GAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000334746.5 | 3UTR | UCAAGUUUCUUAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
109 hsa-miR-302b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT088427 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 4 | ||||||||
MIRT142406 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT162006 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT170893 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT203348 | CCNT2 | cyclin T2 | 2 | 4 | ||||||||
MIRT207353 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT208232 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 4 | ||||||||
MIRT214733 | HSPA9 | heat shock protein family A (Hsp70) member 9 | 2 | 2 | ||||||||
MIRT254842 | NUP50 | nucleoporin 50 | 2 | 2 | ||||||||
MIRT257285 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT338890 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT400032 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT404031 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 8 | ||||||||
MIRT405843 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 2 | ||||||||
MIRT445847 | FPGT | fucose-1-phosphate guanylyltransferase | 2 | 2 | ||||||||
MIRT446350 | EML6 | echinoderm microtubule associated protein like 6 | 2 | 2 | ||||||||
MIRT446649 | BTBD7 | BTB domain containing 7 | 2 | 2 | ||||||||
MIRT447925 | SCRN1 | secernin 1 | 2 | 2 | ||||||||
MIRT448575 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT463616 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT465782 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT470261 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT471090 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT475612 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT476824 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT483107 | TYRP1 | tyrosinase related protein 1 | 2 | 10 | ||||||||
MIRT500537 | XPO4 | exportin 4 | 2 | 2 | ||||||||
MIRT502525 | EPHA2 | EPH receptor A2 | 2 | 4 | ||||||||
MIRT510989 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512540 | ZNF793 | zinc finger protein 793 | 2 | 4 | ||||||||
MIRT513868 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT520756 | TFDP1 | transcription factor Dp-1 | 2 | 6 | ||||||||
MIRT524304 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526306 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 2 | 2 | ||||||||
MIRT526378 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT527438 | COL4A3 | collagen type IV alpha 3 chain | 2 | 2 | ||||||||
MIRT527511 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT528068 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT528367 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 4 | ||||||||
MIRT531804 | TFCP2L1 | transcription factor CP2 like 1 | 2 | 2 | ||||||||
MIRT532323 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT532431 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT534523 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT536660 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT538488 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538593 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT539706 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT540306 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT546892 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT552738 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT552781 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT553742 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 4 | ||||||||
MIRT553909 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT554540 | RRS1 | ribosome biogenesis regulator homolog | 2 | 2 | ||||||||
MIRT555319 | PPP2CB | protein phosphatase 2 catalytic subunit beta | 2 | 2 | ||||||||
MIRT555512 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT556221 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT556292 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT556606 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT556901 | ISOC1 | isochorismatase domain containing 1 | 2 | 2 | ||||||||
MIRT557675 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT560198 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT560493 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT566069 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT568431 | GDNF | glial cell derived neurotrophic factor | 2 | 2 | ||||||||
MIRT570703 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT571705 | RPL36A-HNRNPH2 | RPL36A-HNRNPH2 readthrough | 2 | 2 | ||||||||
MIRT573152 | ITGA9 | integrin subunit alpha 9 | 2 | 2 | ||||||||
MIRT574410 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT614823 | PVRL4 | nectin cell adhesion molecule 4 | 2 | 2 | ||||||||
MIRT616507 | COX7A2L | cytochrome c oxidase subunit 7A2 like | 2 | 2 | ||||||||
MIRT618301 | COL4A4 | collagen type IV alpha 4 chain | 2 | 2 | ||||||||
MIRT621188 | FAM153B | family with sequence similarity 153 member B | 2 | 2 | ||||||||
MIRT621594 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT623814 | GGCX | gamma-glutamyl carboxylase | 2 | 2 | ||||||||
MIRT624407 | CCDC171 | coiled-coil domain containing 171 | 2 | 2 | ||||||||
MIRT625136 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT626121 | MRRF | mitochondrial ribosome recycling factor | 2 | 2 | ||||||||
MIRT626874 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT627874 | PAN2 | PAN2 poly(A) specific ribonuclease subunit | 2 | 2 | ||||||||
MIRT633670 | FAM53B | family with sequence similarity 53 member B | 2 | 2 | ||||||||
MIRT634285 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT640925 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT642028 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT643031 | CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 2 | 2 | ||||||||
MIRT646122 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT646245 | SNAP47 | synaptosome associated protein 47 | 2 | 2 | ||||||||
MIRT652457 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT657018 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT660586 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT664316 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT667113 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT668773 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT698430 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT700216 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT710498 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT711836 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713226 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT714415 | TBC1D16 | TBC1 domain family member 16 | 2 | 2 | ||||||||
MIRT714490 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT715254 | F9 | coagulation factor IX | 2 | 2 | ||||||||
MIRT716250 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT717261 | BMPR2 | bone morphogenetic protein receptor type 2 | 2 | 2 | ||||||||
MIRT717730 | FGF1 | fibroblast growth factor 1 | 2 | 2 | ||||||||
MIRT719262 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719398 | SLC15A4 | solute carrier family 15 member 4 | 2 | 2 | ||||||||
MIRT720653 | TMEM218 | transmembrane protein 218 | 2 | 2 | ||||||||
MIRT720777 | MSANTD3-TMEFF1 | MSANTD3-TMEFF1 readthrough | 2 | 2 | ||||||||
MIRT722059 | TMEFF1 | transmembrane protein with EGF like and two follistatin like domains 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|